'en:platelet finding'
(id=8558051 ; fe=en:platelet finding ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=2222 creation date=2017-07-31 touchdate=2025-08-21 11:10:54.000) ≈ 19 relations sortantes
- en:platelet finding --
r_associated #0: 35 / 1 ->
en:blood coagulation pathway observation
n1=en:platelet finding | n2=en:blood coagulation pathway observation | rel=r_associated | relid=0 | w=35
- en:platelet finding --
r_associated #0: 35 / 1 ->
en:red blood cell finding
n1=en:platelet finding | n2=en:red blood cell finding | rel=r_associated | relid=0 | w=35
- en:platelet finding --
r_associated #0: 32 / 0.914 ->
en:anticoagulant effect
n1=en:platelet finding | n2=en:anticoagulant effect | rel=r_associated | relid=0 | w=32
- en:platelet finding --
r_associated #0: 32 / 0.914 ->
en:white blood cell finding
n1=en:platelet finding | n2=en:white blood cell finding | rel=r_associated | relid=0 | w=32
- en:platelet finding --
r_associated #0: 31 / 0.886 ->
en:thrombotic tendency observations
n1=en:platelet finding | n2=en:thrombotic tendency observations | rel=r_associated | relid=0 | w=31
- en:platelet finding --
r_associated #0: 30 / 0.857 ->
en:clinical evaluation
n1=en:platelet finding | n2=en:clinical evaluation | rel=r_associated | relid=0 | w=30
- en:platelet finding --
r_associated #0: 30 / 0.857 ->
en:fibrinolytic system finding
n1=en:platelet finding | n2=en:fibrinolytic system finding | rel=r_associated | relid=0 | w=30
- en:platelet finding --
r_associated #0: 30 / 0.857 ->
en:finding of anticoagulant control
n1=en:platelet finding | n2=en:finding of anticoagulant control | rel=r_associated | relid=0 | w=30
- en:platelet finding --
r_associated #0: 30 / 0.857 ->
en:tendency to bleed - finding
n1=en:platelet finding | n2=en:tendency to bleed - finding | rel=r_associated | relid=0 | w=30
- en:platelet finding --
r_associated #0: 29 / 0.829 ->
en:normal hemostatic function
n1=en:platelet finding | n2=en:normal hemostatic function | rel=r_associated | relid=0 | w=29
- en:platelet finding --
r_associated #0: 29 / 0.829 ->
en:thrombophilia
n1=en:platelet finding | n2=en:thrombophilia | rel=r_associated | relid=0 | w=29
- en:platelet finding --
r_associated #0: 26 / 0.743 ->
en:fibrinogen screening finding
n1=en:platelet finding | n2=en:fibrinogen screening finding | rel=r_associated | relid=0 | w=26
- en:platelet finding --
r_associated #0: 25 / 0.714 ->
en:platelet
n1=en:platelet finding | n2=en:platelet | rel=r_associated | relid=0 | w=25
- en:platelet finding --
r_associated #0: 20 / 0.571 ->
en:hypercoagulable state
n1=en:platelet finding | n2=en:hypercoagulable state | rel=r_associated | relid=0 | w=20
- en:platelet finding --
r_associated #0: 20 / 0.571 ->
état d'hypercoagulabilité
n1=en:platelet finding | n2=état d'hypercoagulabilité | rel=r_associated | relid=0 | w=20
- en:platelet finding --
r_associated #0: 20 / 0.571 ->
état hypercoagulable
n1=en:platelet finding | n2=état hypercoagulable | rel=r_associated | relid=0 | w=20
- en:platelet finding --
r_associated #0: 20 / 0.571 ->
hypercoagulabilité
n1=en:platelet finding | n2=hypercoagulabilité | rel=r_associated | relid=0 | w=20
- en:platelet finding --
r_associated #0: 20 / 0.571 ->
hypercoagulabilité sanguine
n1=en:platelet finding | n2=hypercoagulabilité sanguine | rel=r_associated | relid=0 | w=20
- en:platelet finding --
r_associated #0: 20 / 0.571 ->
thrombophilie
n1=en:platelet finding | n2=thrombophilie | rel=r_associated | relid=0 | w=20
| ≈ 22 relations entrantes
- hypercoagulabilité ---
r_associated #0: 374 -->
en:platelet finding
n1=hypercoagulabilité | n2=en:platelet finding | rel=r_associated | relid=0 | w=374
- en:thrombophilia ---
r_associated #0: 370 -->
en:platelet finding
n1=en:thrombophilia | n2=en:platelet finding | rel=r_associated | relid=0 | w=370
- thrombophilie ---
r_associated #0: 333 -->
en:platelet finding
n1=thrombophilie | n2=en:platelet finding | rel=r_associated | relid=0 | w=333
- état d'hypercoagulabilité ---
r_associated #0: 253 -->
en:platelet finding
n1=état d'hypercoagulabilité | n2=en:platelet finding | rel=r_associated | relid=0 | w=253
- hypercoagulabilité sanguine ---
r_associated #0: 245 -->
en:platelet finding
n1=hypercoagulabilité sanguine | n2=en:platelet finding | rel=r_associated | relid=0 | w=245
- état hypercoagulable ---
r_associated #0: 243 -->
en:platelet finding
n1=état hypercoagulable | n2=en:platelet finding | rel=r_associated | relid=0 | w=243
- en:hypercoagulable state ---
r_associated #0: 32 -->
en:platelet finding
n1=en:hypercoagulable state | n2=en:platelet finding | rel=r_associated | relid=0 | w=32
- en:anticoagulant effect ---
r_associated #0: 30 -->
en:platelet finding
n1=en:anticoagulant effect | n2=en:platelet finding | rel=r_associated | relid=0 | w=30
- en:blood coagulation pathway observation ---
r_associated #0: 30 -->
en:platelet finding
n1=en:blood coagulation pathway observation | n2=en:platelet finding | rel=r_associated | relid=0 | w=30
- en:clinical evaluation ---
r_associated #0: 30 -->
en:platelet finding
n1=en:clinical evaluation | n2=en:platelet finding | rel=r_associated | relid=0 | w=30
- en:tendency to bleed - finding ---
r_associated #0: 30 -->
en:platelet finding
n1=en:tendency to bleed - finding | n2=en:platelet finding | rel=r_associated | relid=0 | w=30
- en:fibrinolytic system finding ---
r_associated #0: 29 -->
en:platelet finding
n1=en:fibrinolytic system finding | n2=en:platelet finding | rel=r_associated | relid=0 | w=29
- en:normal hemostatic function ---
r_associated #0: 29 -->
en:platelet finding
n1=en:normal hemostatic function | n2=en:platelet finding | rel=r_associated | relid=0 | w=29
- en:finding of anticoagulant control ---
r_associated #0: 27 -->
en:platelet finding
n1=en:finding of anticoagulant control | n2=en:platelet finding | rel=r_associated | relid=0 | w=27
- en:red blood cell finding ---
r_associated #0: 27 -->
en:platelet finding
n1=en:red blood cell finding | n2=en:platelet finding | rel=r_associated | relid=0 | w=27
- en:white blood cell finding ---
r_associated #0: 26 -->
en:platelet finding
n1=en:white blood cell finding | n2=en:platelet finding | rel=r_associated | relid=0 | w=26
- en:thrombotic tendency observations ---
r_associated #0: 23 -->
en:platelet finding
n1=en:thrombotic tendency observations | n2=en:platelet finding | rel=r_associated | relid=0 | w=23
- en:fibrinogen screening finding ---
r_associated #0: 21 -->
en:platelet finding
n1=en:fibrinogen screening finding | n2=en:platelet finding | rel=r_associated | relid=0 | w=21
- Thrombophilie ---
r_associated #0: 20 -->
en:platelet finding
n1=Thrombophilie | n2=en:platelet finding | rel=r_associated | relid=0 | w=20
- Hypercoagulabilité ---
r_associated #0: 10 -->
en:platelet finding
n1=Hypercoagulabilité | n2=en:platelet finding | rel=r_associated | relid=0 | w=10
- observation de la voie de coagulation sanguine ---
r_associated #0: 10 -->
en:platelet finding
n1=observation de la voie de coagulation sanguine | n2=en:platelet finding | rel=r_associated | relid=0 | w=10
- thrombolytique (traitement) ---
r_associated #0: 5 -->
en:platelet finding
n1=thrombolytique (traitement) | n2=en:platelet finding | rel=r_associated | relid=0 | w=5
|